Develops nuclear-delivered antibody-drug conjugates to target tumor cells and blood vessels, creating innovative cancer treatments.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Angiex is pioneering the development of innovative cancer treatments through its Nuclear-Delivered Antibody-Drug Conjugates (ND-ADCs). By targeting tumor cells and blood vessels within solid cancers, the company aims to deliver highly effective therapies with a greater therapeutic margin. Their lead drug, AGX101, is nearing clinical trials, and they have additional therapies in development to address the most challenging aspects of cancer.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Angiex Management Team
Angiex Valuations & Financials
View real-time NPM data on Angiex stock including daily Angiex stock price estimates, valuation history, and historical share price information. Access Angiex financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Angiex pricing across six independent market signals. Looking for private company due diligence data sources on Angiex? Get in touch to learn more.
Similar Companies
like Angiex
Isolation Bio
Healthcare & Life Sciences
Unlocks microbial diversity that isolates and cultivates rare microbes at scale for discovery and product development.
VoiceCare AI
Healthcare & Life Sciences
Voice agent automating provider–payer calls that streamlines authorizations, claims, and verifications with detailed documentation.
Aro Biotherapeutics
Healthcare & Life Sciences
Develops tissue-targeted genetic medicines using proprietary protein technology to deliver therapeutic oligonucleotides to specific cells.
Flashback
Healthcare & Life Sciences
Develops a machine learning platform that analyzes physiological data to support clinical decision-making in trauma and critical care environments.
Neurona Therapeutics
Healthcare & Life Sciences
Provides discovery of regenerative cell-based therapeutics to treat intractable neurological disease.
AdaptX
Healthcare & Life Sciences
Deliver digital financial products using integrated infrastructure for payments, wallets, and compliance.
Zafrens
Healthcare & Life Sciences
Platform technology that isolates, cultures, and analyzes millions of cells daily, correlating molecular profiles with cell phenotype and function.
Artisight
Healthcare & Life Sciences
Enables ambient clinical monitoring which automates tasks and elevates care delivery.
Nimblemind.ai
Healthcare & Life Sciences
Streamlines clinical dataset curation and enrichment for healthcare organizations, enhancing data quality and research capabilities.
FAQ
We have answers
Angiex stock does not trade on public stock exchanges. Angiex stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Angiex stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Angiex Stock does not trade on public stock exchanges. In order to sell Angiex shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Angiex does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Angiex share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Angiex stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Angiex stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Angiex stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Angiex is a private company and has not had an IPO. There is currently no Angiex IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Angiex IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
